Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
Titel:
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
Auteur:
Bauer, Axel Schreinlechner, Michael Sappler, Nikolay Dolejsi, Theresa Tilg, Herbert Aulinger, Benedikt A Weiss, Günter Bellmann-Weiler, Rosa Adolf, Christian Wolf, Dominik Pirklbauer, Markus Graziadei, Ivo Gänzer, Hannes von Bary, Christian May, Andreas E Wöll, Ewald von Scheidt, Wolfgang Rassaf, Tienush Duerschmied, Daniel Brenner, Christoph Kääb, Stefan Metzler, Bernhard Joannidis, Michael Kain, Hans-Ulrich Kaiser, Norbert Schwinger, Robert Witzenbichler, Bernhard Alber, Hannes Straube, Florian Hartmann, Niels Achenbach, Stephan von Bergwelt-Baildon, Michael von Stülpnagel, Lukas Schoenherr, Sebastian Forer, Lukas Embacher-Aichhorn, Sabine Mansmann, Ulrich Rizas, Konstantinos D Massberg, Steffen